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Introduction
It is well known that acute or chronic increase of left ventricular end-diastolic pressure, induced by several 
pathological conditions, could fatally induce a change in both atrial structure and function. Accordingly, in 
chronic heart failure (CHF) (Joung et al 2010a, 2010b) the electromechanical atrial remodeling, the sinus node 
dysfunction and supraventricular arrhythmias have been described. During healthy condition, the autonomic 
nervous system (ANS) modulates the sinus node activity, leading to the well-known oscillatory behavior of 
heart rate, due to the opposite and alternating vagal and sympathetic activity. Conversely, several cardiovascular 
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Abstract
Objective: The relationship between the autonomic nervous system (ANS) modulation of the 
sinus node and heart rate variability has been extensively investigated. The current study sought to 
evaluate, in an animal experimental model of pacing-induced tachycardia congestive heart failure 
(CHF), a possible ANS influence on the P wave duration and PR interval oscillations. Approach: 
Short-term (5 min) time and frequency domain analysis has been obtained in six dogs for the 
following electrocardiographic intervals: P wave duration (P), from the onset to peak of P wave (Pp), 
from the onset of P wave to the q onset (PR) and from the end of P wave to the onset of q wave (PeR). 
Direct vagal nerve activity (VNA), stellate ganglion nerve activity (SGNA) and electrocardiogram 
(ECG) intervals have been evaluated contextually by implantation of three bipolar recording 
leads. Main results: At the baseline, multiple regression analysis pointed out that VNA was strongly 
positively associated with the standard deviation of PP and PeR intervals (r2:0.997, p  <  0.05). The 
same variable was also positively associated with high-frequency (HF) of P expressed in normalized 
units, of Pp, and of PeR (b: 0.001) (r2: 0.993; p  <  0.05). During CHF, most of the time and frequency 
domain variability significantly decreased from 20% to 50% in comparison to the baseline values 
(p  <  0.05) and SGNA correlated inversely with the low frequency (LF) obtained from PeR (p  <  0.05) 
and PR (p  <  0.05) (r2:0.899, p  <  0.05). LF components, expressed in absolute and normalized power, 
obtained from all studied intervals, were reduced significantly during CHF. Any difference between 
the RR and PP spectral components was observed. Significance: The data showed a significant 
relationship between ANS and atrial ECG variables, independent of the cycle duration. In particular, 
the oscillations were vagal mediated at the baseline, while sympathetic mediated during CHF. 
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diseases are often associated with ANS imbalance with a sympathetic over-activity, which in turn is able to 
provoke a significant reduction of the heart rate variability (HRV) (Mortara et al 1994, Guzzetti et al 1995, 
Piccirillo et al 2006, 2009a). Thus, the oscillatory activity of the sinus node constantly and indirectly may provide 
useful insight into atrial and ventricular functions (Piccirillo et al 2016a, 2016b). Oscillatory activity originates 
in the sinus node and it spreads to the atria, the atrioventricular node and then to the ventricles. Although the RR 
interval variability is thought to be an exact surrogate of the PP interval variability, these two electrocardiographic 
intervals pertain to different cardiac chambers. Indeed, both atrial and ventricular damage could affect the 
supraventricular conduction system and hence the PP oscillations precede temporally those of the RR intervals 
(Horner et al 1996). The abovementioned extreme sensitivity of the supraventricular conduction systems to 
possible structural and functional heart changes raises interest in investigating possible earlier markers of ANS 
imbalance.
The previous studies on the HRV during CHF, focusing on the RR intervals, reported an RR variability reduc-
tion, expressed as time and frequency domain variables in short- and long-period electrocardiogram (ECG) 
recordings. In particular, in CHF the reduction of an RR spectral component, called low-frequency (LF) power, 
was related to the increase of left ventricular end diastolic pressure (Horner et al 1996), sinus dysfunction 
(Piccirillo et al 2009b), clinical progression of disease (Mortara et al 1994, Guzzetti et al 1995, Van de Borne et al 
1997, Piccirillo et al 2004, 2006, Sanders et al 2004) and, moreover, the risk of sudden cardiac death (La Rovere 
et al 2003) and mortality (Guzzetti et al 2005) in both human and experimental models.
Obviously, the RR and PP power spectral analysis showed similar results and were then extensively stud-
ied, but we have few data on the intrinsic oscillations of the P wave and PR segment in CHF and in relation to 
autonomic control. Previous observations showed a reduction of PQ–PP and Pp–PP spectral coherence in CHF 
patients in comparison with normal subjects; these data could indicate atrial distress during an increase of left 
ventricular end-diastolic pressure and atrial enlargement.
The aim of this study was to evaluate the influence of ANS on the P wave and PR interval oscillations in CHF 
in order to understand if these variables could be used as a marker of autonomic influence, compared to the 
direct recording of stellate ganglia and vagal nerve activities (VNAs), on sinus and atrioventricular nodes.
Materials and methods
Surgical preparation and electrical recording
The data analyzed came from a previous study conducted in six female dogs (Ogawa et al 2007, Choi et al 2010, 
Han et al 2012). The surgical procedures and temporal relationship between cardiac arrhythmia and ANS activity 
are reported in detail elsewhere (Ogawa et al 2007, Choi et al 2010, Han et al 2012). Briefly, a pacing lead was 
implanted in the right ventricular apex and connected to an Itrel neurostimulator (Medtronic, Minneapolis, MN, 
USA) in a subcutaneous pocket. We then implanted a Data Sciences International (DSI) D70-EEE transmitter 
with three bipolar recording channels for simultaneous recording of the left stellate ganglion nerve activity 
(SGNA), VNA from the left thoracic vagal nerve located above the aortic arch, and subcutaneous ECG. After 
implantation, the Itrel stimulator was initially turned off for two weeks to allow the dogs to recover from surgery 
and to allow us to obtain the baseline recordings. The stimulator was then programmed to pace at 150 bpm for 
3 d, at 200 bpm for 3 d, and then at 250 bpm for 3 weeks to induce CHF. The pacemaker was then turned off to 
allow an additional two weeks of ambulatory monitoring and recording during CHF. All CHF data were recorded 
within the first week. All animals underwent the same protocol with regard to intensity and duration of pacing. 
The animal experiments were approved by the Institutional Animal Care and Use Committee of the Cedars-Sinai 
Medical Center, Los Angeles, California.
Direct measurement of autonomic nervous activity
Data were recorded in real time at a sampling rate of 1000 samples s−1 per channel, then analyzed off-line. The 
software used has been described elsewhere (Ogawa et al 2007, Choi et al 2010, Han et al 2012). In brief, to analyze 
long-term trends in the large segmented data files effectively, a custom-designed program was developed using 
Labview™ (National Instruments, Austin, Texas, USA) software to automatically import, filter and analyze the 
DSI transmitter data for ANS activities and heart rates. The software determined the activation cycle length (RR 
intervals) automatically derived from the ECG (based on a Hilbert transform algorithm (Benitez et al 2001). 
Integrated data from the SGNA and VNA were high-pass (200 Hz) filtered and rectified over a fixed time segment 
to represent the total nerve activity. Because RR intervals shorter than 200 ms were usually due either to ectopic 
beats, artifacts or rhythm disturbances, they were removed and excluded from the analysis.
To assess ANS activity, we randomly selected six short-term recordings (5 min ECG) for each dog at the base-
line and after pacing-induced CHF. Moreover, nerve activity data were also calculated over 24 h, namely in a total 
of 288 of 5 min epochs; finally, we calculated the means of these data and reported them as 24 h SGNA and VNA.
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HRV power spectral analysis
We calculated the following intervals from 5 min epochs of ECG recordings: RR, PP, P wave (from onset to end of 
P wave), PR (from the onset of P wave to onset of q wave), and Pp (between the onset and the peak of P wave) and 
PeR (from the end of P wave to the onset of q wave) intervals (figure 1).
We measured the mean, variance and standard deviation (SD) values for each interval. In particular, the value 
obtained for each variable was the mean of six-sample measurements before and after pacing-induced CHF, in 
the six dogs studied.
We used an autoregressive algorithm to compute the power spectral density from the different ECG variables 
(Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysi-
ology 1996). From a series of 5 min of consecutive beats, the autocorrelation function was applied to the com-
plete RR, Pp, PR, P, PeR, and PP series, and the Yule–Walker matrix (autocorrelation value matrix) was calculated 
with the Levinson–Darbin method; the matrix order was determined with an Anderson test and Akaike Infor-
mation Criteria. The spectral decomposition method was then applied for the estimation of power and central 
frequency of each spectral component. Spectral power of each variable is expressed in milliseconds squared. The 
frequencies of the RR, Pp, PR, P, PeR, and PP oscillations divided by the mean RR, Pp, PR, P, PeR, and PP values, 
respectively expressed in milliseconds, were calculated in cycles per beat and converted to herz equivalents. We 
then determined the following power spectral variables in absolute power expressed in milliseconds squared of 
the RR, Pp, PR, P, PeR, and PP intervals: total spectral power (TP) or root square of variance are expressed as SD; 
the high-frequency (HF) component (from 0.15–0.40 Hz); LF component (from 0.04–0.15 Hz) (Piccirillo et al 
2004, 2009a, Magrì et al 2012).
Thereafter, the coherence function for the RR and the various repolarization intervals was estimated  (Piccirillo 
et al 2009a, 2016a, 2016b, Baumert et al 2016). Coherence expresses the power fraction oscillating at a given 
 frequency in either time series and is explained as a linear transformation of the other, thus indicating a linear 
association between the two signals. The coherence function γ( f ) was then computed according to the formula:
Coherence ( f )
∣∣Pxy( f )∣∣2
Pxx( f )Pyy( f )
where f is frequency, Pxx ( f ) is the spectrum of an obtained variable (PR, Pp, P or RR), Pyy( f ) are the other studied 
spectral variables (PP, PR, or PeR), and Pxy( f ) is the cross-spectrum (PR–PP, Pp–PP, P–PR, P–PeR, or RR–PP).
The coherence function provides a measure between zero and unity in the degree of linear interaction 
between the different studied interval oscillations as a function of their frequency. Mean coherences were meas-
ured by averaging γ( f ) over the frequency bands: from 0–0.50 Hz.
To detect the ECG intervals, we used a classic adaptive first derivative/threshold algorithm, explained else-
where (Arzeno et al 2008). Also, to acquire, store and analyze the ECG data, we used our designed and produced 
software using Labview™ (National Instruments, Austin, Texas, USA). A cardiologist (GP) checked the different 
ECG wave and intervals, automatically marked by the software, and, when needed, manually corrected the mis-
takes. The premature beats and excessive noise were causes of possible mistakes in the interval measurement, so 
we have not considered in the analysis recordings with more than three premature beats.
At the baseline and after the pacing-induced CHF, the left ventricular ejection fraction, by echocardiographic 
study, and plasma levels of norepinephrine N-terminal and pro-B type natriuretic peptide (NT-proBNP) were 
evaluated.
Statistical analysis
Unless otherwise indicated, all data are expressed as mean  ±  SD. Data with skewed distribution are given as 
median and interquartile range (75th percentile—25th percentile).
Figure 1. Pp (1), PeR (2), PR (4), PP (5), RR (6) intervals and P (3) wave duration.
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In the present study, we analyzed six ECG registrations for the dogs at the baseline and after pacing-induced 
CHF. Therefore, we used the mean of six values for each variable for the statistical analysis at the baseline and after 
pacing-induced CHF. In conclusion, each variable was measured 36 (six dogs for six recordings) times before and 
after pacing-induced CHF.
The paired t-test was used to compare data for the normally distributed variables (including mean and SD of 
ECG variables, coherence functions, etc), whereas the Wilcoxon test was used to compare non-normally distrib-
uted variables (including variance and spectral components in absolute power of RR, Pp, PR, P, PeR, and PP inter-
vals and plasma levels of norepinephrine and NT-proBNP) at the baseline and after CHF. A stepwise multiple 
regression analysis was constructed to study possible associations between variables. In particular, we consider 
SGNA or VNA as a dependent variable and spectral and non-spectral (RR, Pp, PR, P, PeR, and PP) studied data as 
independent variables at the baseline and after pacing-induced CHF.
Results
After pacing-induced CHF, in all six dogs, we obtained a significant reduction of ejection fraction (p  <  0.0001) 
and a significant increase of norepinephrine (p  <  0.01) and NT-proBNP levels in peripheral blood flow 
(p  <  0.05) (Ogawa et al 2007). The voltage of the P wave was not significantly different between the baseline and 
CHF.
During the CHF period, the SDs of all variables (RR, PP, Pp, P, and PeR) showed a significant reduction in 
comparison with the baseline period (p  <  0.05) (table 1).
Similarly, the TP of each variable was lower during CHF. Finally, during CHF, PR–PP, Pp–PP, and P–PeR spec-
tral coherences were lower than at the baseline condition (p  <  0.05 for all) (table 1).
In short-term study conditions, only the SGNA value was significantly higher during CHF (p  <  0.05) (table 
1). Conversely, both the 24 h SGNA (p  <  0.0001) and 24 h VNA were significantly higher (p  <  0.0001) during 
CHF (table 1).
LF, expressed in absolute power, was significantly lower during CHF in all studied variables (Pp, P, PR and 
PeR) (figure 2).
LF, expressed in normalized units (NUs), confirmed the same behavior only for Pp and PR (figure 3).
Conversely, only HF absolute power of P was significantly lower during CHF in comparison with the baseline 
(baseline median: 42 ms2, interquartile range: 46 ms2 versus CHF median: 21 ms2, interquartile range: 10 ms2). 
We did not find any difference in the matrix order between the baseline and CHF period (baseline 17  ±  8 versus 
CHF: 20  ±  6, p: ns). We did not observe any difference between the RR and PP spectral components.
Table 1. ECG variables at the baseline and during CHF.
Variables Baseline N  =  6 CHF N  =  6 P values
RR mean, ms 768  ±  66 651  ±  97 NS
RR SD, 300  ±  44 160  ±  48 0.009
PP mean, ms 767  ±  67 651  ±  96 NS
PP SD, 305  ±  40 161  ±  47 0.006
Pp mean, ms 48  ±  17 49  ±  19 NS
Pp SD, 9  ±  3 7  ±  2 0.032
PR mean, ms 149  ±  30 143  ±  23 NS
PR SD, 7  ±  2 5  ±  2 0.020
P mean, ms 95  ±  26 91  ±  25 NS
P SD, 10  ±  3 8  ±  2 0.047
PeR mean, ms 54  ±  9 53  ±  8 NS
PeR SD, 9  ±  2 4  ±  2 0.000
PR–PP, coherence 0.275  ±  0.111 0.161  ±  0.028 0.048
Pp–PP, coherence 0.317  ±  0.075 0.223  ±  0.069 0.030
P–PR, coherence 0.564  ±  0.126 0.654  ±  0.111 NS
P–PeR, coherence 0.666  ±  0.065 0.488  ±  0.167 0.014
RR–PP, coherence 0.970  ±  0.038 0.961  ±  0.030 NS
SGNA (µV/sample) 0.29  ±  0.20 0.43  ±  0.24 0.039
VNA (µV/sample) 0.11  ±  0.02 0.14  ±  0.06 NS
SGNA 24 h (µV/sample) 0.47  ±  0.09 0.62  ±  0.31 0.0001
VNA 24 h (µV/sample) 0.009  ±  0.003 0.026  ±  0.02 0.0001
Data are expressed as mean  ±  SD. SGNA: integrated left stellate ganglion nerve activity; VNA: integrated vagal nerve activity. NS: not 
significant.
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With regard to short-term time and frequency domain data, the stepwise multiple regression analysis showed 
a significant inverse relation at the baseline between SGNA and PeR SDs (r: 0.937; b:  −  0.180, p  <  0.05) and the 
HF of P (r: 0.912; b:  −  0.016, p  <  0.05), expressed in NUs (figure 4).
In contrast, the VNA was positively associated with SD of PP (b: 0.002) and PeR (b:0.000) intervals (r:0.9998, 
p  <  0.05) (figure 5(A)). The same nerve variable was also positively associated with the HF of P expressed in NUs 
(b:0.002), of Pp (b:0.000), and of PeR (b:0.001) (r:0.998; p  <  0.05) (figure 5(B)).
Conversely, during CHF, the stepwise multiple regression analysis showed just a significant inverse relation 
between SGNA and the LF of PeR, expressed in NUs, (r:0.948; b:  −0.027, p  <  0.01) (figure 6).
Discussion
The major and novel finding of the study was that pacing-induced tachycardia CHF produced a reduction of the 
temporal variability of the P wave duration and of Pp, PeR, and PR intervals. In particular, all the short-term atrial 
ECG time-variables showed a reduction, expressed in SD, in CHF. Contextually, during CHF, a global reduction 
of LF power has been observed.
In fact, changes in the ANS modulation of the sinus node autonomic, together with a neuro-humoral and 
inflammatory activation, are common CHF features possibly related to an increased risk of atrial arrhythmias. 
A simultaneous increase in sympathetic and VNA has been described at the atrial level (Choi et al 2010, Han et al 
2012), with the vagal activity increase being most likely a compensatory attempt to reduce the final sympathetic 
Figure 2. LF component of different tested variables at the baseline (bsl) and after pacing-induced tachycardia CHF. In the box 
plots, the central line represents the median distribution. Each box spans from the 25th to 75th percentile points, and error bars 
extend from the 10th to 90th percentile points.
Figure 3. Comparisons of LF, expressed in NUs, at the baseline and after pacing-induced tachycardia CHF. In the box plots, the 
central line represents the median distribution. Each box spans from the 25th to 75th percentile points, and error bars extend from 
the 10th to 90th percentile points.
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hyperactivity. The abovementioned ANS imbalance leads to an increased temporal dispersion of refractory peri-
ods of the atrial myocytes, which in turn represents a trigger for atrial arrhythmias (i.e. atrial fibrillation). The 
observed reduction of variability of the atrial related ECG parameters during CHF, similar to those of the RR 
variability (Piccirillo et al 2009b), could be the direct consequence of this peculiar and proarrhythmic auto-
nomic control (Piccirillo et al 2016a, 2016b). Interestingly, the reduced variability of these atrial variables was 
independent of the heart rate in this new experimental model (ECG recordings with similar heart rate analyzed) 
(Zaza and Lombardi 2001). In fact, in the pacing-induced CHF condition, we observed an equal level of VNA 
compared with the baseline even at the same heart rate. On the other hand, we found a higher VNA level on 24 h 
nerve recordings during CHF. Thus, although the higher levels of VNA could seem a paradox, it seems to be a 
compensatory mechanism to oppose the increase of SGNA (Choi et al 2010, Ogawa et al 2010, Han et al 2012). 
Further support to this VNA behavior, comes from the CHF-related upregulation of the muscarinic receptors 
(M2) reported in both human and animal models (DeMazumder et al 2015). Furthermore, this increase of vagal 
activity could be interpreted as an increase of vagal afferent activity related to the increase of end diastolic pres-
sure and atrial distention in CHF.
Moreover, we observed that the VNA influenced prevalently the SD (time domain variables) of the PeR and 
PP intervals and the HF (frequency domain variables) of the P wave duration at the baseline. Conversely, the 
Figure 4. At the top panel (A), the multiple regression analysis between SGNA (dependent variable) and SD obtained from the PeR 
interval at the baseline (significant independent variable). In (B), the same analysis between SGNA (dependent variable) and HF, 
expressed in NUs, obtained from the P wave duration at the baseline (significant independent variable).
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SGNA had no influence on any atrial time domain variables. This finding is not unexpected, because the HRV 
expressed as SD in short-term ECG recordings is a marker of vagal activity (Task Force of the European Society 
of Cardiology and the North American Society of Pacing and Electrophysiology 1996) and, hence, the positive 
relation between VNA and the PP interval SD confirms that this parameter could be considered a noninvasive 
marker of vagal atrial activity under healthy condition. In fact, undiscussed specific papers in this field, albeit 
dated, reported that the vagal pharmacological suppression induces a dramatic reduction of the short period of 
SD of RR and for this reason, all spectral components (Pomeranz et al 1985, Koh et al 1994, Després et al 2002, 
Laude et al 2008). Finally, this reduction was found to be abolished in the absence of VNA (Epstein et al 1990). In 
addition, our data suggest that these atria variables are probably more reliable than RR variability for sinus vagal 
activity (i.e. stepwise multivariable analysis did not show a significant relation between RR SD and the VNA). 
Indeed, atria, sinus node and atrioventricular node are extensively innervated by parasympathetic nerves. Thus, 
we could consider that particularly the PeR interval represents the best noninvasive surrogate of the electrical 
conduction between the atrioventricular node and the His bundle. On the other hand, the atrial spectral markers, 
Figure 5. At the top panel (A) the multiple regression analysis between VNA (dependent variable) and PP intervals and SD obtained 
from the PeR at the baseline (significant independent variables). In (B), the same analysis between VNA (dependent variable) and the 
HF, expressed in NUs, obtained from the P wave duration, Pp and PeR intervals at the baseline (significant independent variables).
Figure 6. Multiple regression analysis between SGNA (dependent variable) and the LF, expressed in NUs, obtained from the PeR 
intervals (significant independent variable) after pacing-induced tachycardia CHF.
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that is the HF of Pp and P, could express the effect of vagal influence on the right and left atria. In fact, the first part 
of the P wave, since the P peak is probably linked to the electrical depolarization of the right atrium (Puech et al 
1974), whereas the total P wave duration is mainly influenced by the left atria. (Chirife et al 1975). In conclusion, 
these spectral variables were markers of vagal effect on both atria in normal condition (figure 5).
In power spectral and time domain atrial variables related to the SGNA, the influence seems to be partially 
coincident in baseline and CHF conditions. In fact, we found an inverse relation between SGNA and PeR vagal-
derived markers in both these experimental conditions. In particular, we found that SD and HF of PeR are char-
acterized by an inverse relationship, expressed in NUs. This datum could indicate that the sympathetic activity, 
recorded in the left stellate ganglion, induced a reduction of vagal activity in the atrioventricular node and in 
His bundle. Naturally, a large and historical pathophysiological literature reported that left side sympatho-vagal 
innervations, as in our study, had a prevalent influence on atrioventricular node function (Cohn et al 1913, Cinca 
et al 1985, Inoue et al 1987, Waninger et al 1999).
The inverse relationship between the left SGNA and VNA seemed to have only one possible and easy explana-
tion: sympathetic activation was able to reduce the vagal activity in atrioventricular node and in His bundle in 
normal and CHF condition, inducing the well-known phenomenon called sympathetic-parasympathetic inter-
action in the A–V conduction system (Salata et al 1986, Levy et al 1988, Brack et al 2004, White et al 2014).
Although the physiological meaning of LF still remains controversial (Parati et al 1995, Sleight et al 1995, 
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiol-
ogy 1996, Moak et al 2007, Piccirillo et al 2009a), the Mayer waves, that cause these oscillations (about 0.10 Hz), 
are reduced in the CHF for the PeR and PR segments in the same way as RR variability (van de Borne et al 1997, 
Piccirillo et al 2006). Moreover, both in human and in experimental CHF models, the LF reduction is related to 
severity of the disease and it is a marker of CHF-related mortality (Mortara et al 1994, van de Borne et al 1997, 
La Rovere et al 2003, Guzzetti et al 2005, Piccirillo et al 2009b). Thus, the LF reduction of atrial variables could 
be considered a noninvasive and inexpensive marker of the degree of dysfunction of the atrial and ventricular 
myocardium.
In conclusion, the atrial ECG-derived intervals showed oscillations similar to those of the RR interval and, 
in normal conditions, they seem to be controlled primarily by VNA. In contrast, during experimental CHF, the 
atrial ECG-derived intervals collapse dramatically, with these reductions related to increased sympathetic nerve 
activity. Thus, different atrial structures seemed to have different oscillatory behavior according to the auto-
nomic control and the presence of CHF. The P wave duration and PR interval oscillation evaluation might be a 
stimulating idea for future research on paroxysmal supraventricular arrhythmias. Moreover, given that the ECG 
yields a simple and transmissible signal, this easy approach could be developed as a remote medical technology, 
thereby saving time and economic resources.
Study limitation
The most important study limitation was the small number of studied animals. However, it should be emphasized 
that we checked every point automatically found by the software for a total of about 150 000 points (five points 
for each beat). Analyzable recordings should be of good quality, avoiding confounding noise (resulting from 
environmental conditions, i.e. dog movements). Thus, we analyzed the study variables in 36 5 min ECG 
recordings at the baseline and after pacing-induced CHF (six baselines and six CHFs for each of the six cases). 
The abovementioned vast amount of work, which took nearly two years, led us to obtain measurements with a 
high level of accuracy.
Another possible limitation was that the HRV, SGNA and VNA were markers of ANS modulation as mean in 
5 min rather than a marker of a moment-to-moment or instantaneous nerve activity. Because the HRV needed 
a stationary period (see figure 3), we also possibly choose a stationary period of nerve activity, and therefore the 
HRV, SGNA and VNA were numerically expressed as mean of 5 min.
The last technical limitation of direct nerve recording was undoubtedly that the adopted approach did not 
permit us to discriminate the afferent from efferent nerve activity. Therefore, we need to consider the possibility 
to have a pure efferent cardiovascular signal.
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